Pain Management Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Live Coverage of PAINWeek 2014

Exclusive access to live, onsite coverage of up-to-date evidence-based scientific findings in pain management.

IBD and Heavy Opioid Use

Clinicians should closely monitor the use of these medications in IBD treatment plans to reduce the risk of heavy subsequent use.

Pharmacies, Clinics Rx Drop-Off Sites

Attorney General Eric Holder stated that the new DEA regulation would help to prevent prescription drug misuse, particularly with opioid medications.

Aleve PM for Overnight Pain

Bayer HealthCare announced the launch of Aleve PM caplets for occasional sleeplessness associated with minor aches and pains.

Neck, Back Pain Improvement Factors

Observational registry-based research can inform patients and physicians about prognosis for subacute or chronic neck or low back pain.

Migraine Prophylactic Therapy

More research needs to be done to understand the reasons for non-adherence for migraine prophylactic therapy.

Pediatricians Prep for Anesthesia

Pediatricians have an important part in preparing surgical patients and their families for procedures, including anesthesia.

New Drug Product: Zubsolv

Maintenance treatment of opioid dependence, as part of a complete treatment plan to include counseling and psychosocial support.

News

NSAIDs May Increase VTE Risk, Although Cause Unclear

Use of nonsteroidal anti-inflammatory drugs (NSAIDs) may increase risk of venous thromboembolism (VTE).

Alternative Pain Management Research for Veterans Announced by NIH

The National Institutes of Health (NIH) has announced thirteen research projects totaling approximately $21.7 million over five years to explore non-drug approaches to pain management and related health conditions in U.S. military personnel, veterans, and their families.

Meditation for Migraines? Pilot Study Shows Promise

Mindfulness-based stress reduction (MBSR) is a safe and practical intervention for adults with migraine headaches, according to new research.

Lannett Launches Oxycodone HCl Oral Solution

Lannett announced it has begun shipping Oxycodone HCl Oral Solution, which was approved earlier this month.

Hydrocodone Combo Product Rescheduling: What You Need to Know

The DEA's Final Rule moving hydrocodone combination products (HCPs) from Schedule III to Schedule II will go into effect starting October 6, but physicians should be prepared for this change in advance to minimize disruptions in patient treatment plans.

Featured courses from mycme

End-of-Life CareExternal web site

Discussing end-of-life issues and palliative care options with patients who have life-limiting illnesses is challenging. ...

CME|CE 1.25 Credits

Pain Management Workshop (Pharmacology Credit)External web site

This program will discuss the causes of chronic pain as well as pharmacological options for ...

CE 3.00 Credits

Debridement Training: Principles & PracticeExternal web site

This course offers practicing physicians, mid-level practitioners, nurses and other allied health professionals a comprehensive ...

CME|CE 4.00 Credits

Sign Up for Free e-newsletters